AAAAAA

   
Results: 1-18 |
Results: 18

Authors: Lader, M
Citation: M. Lader, Maintaining response to antidepressants, PRIM CARE P, 7(2), 2001, pp. 75-78

Authors: Lader, M
Citation: M. Lader, Drug effects on psychomotor performance, ADDICTION, 96(6), 2001, pp. 917-917

Authors: Lader, M
Citation: M. Lader, Debate on the prescribing of injectable drugs to addicts - Injectable opiate maintenance in the United Kingdom - within a Medicines Act perspective, ADDICTION, 96(4), 2001, pp. 555-557

Authors: Lepine, JP Altamura, C Ansseau, M Gutierrez, JLA Bitter, I Lader, M Waintraub, L
Citation: Jp. Lepine et al., Tianeptine and paroxetine in major depressive disorder, with a special focus on the anxious component in depression: an international, 6-week double-blind study, HUM PSYCHOP, 16(3), 2001, pp. 219-227

Authors: Lader, M
Citation: M. Lader, Editorial: Exciting new developments for contributors and subscribers, J INT MED R, 29(1), 2001, pp. 1-1

Authors: Lader, M Morris, R
Citation: M. Lader et R. Morris, Carbon monoxide poisoning, J ROY S MED, 94(10), 2001, pp. 552-552

Authors: Lader, M Cowen, P
Citation: M. Lader et P. Cowen, Depression - Preface, BR MED B, 57, 2001, pp. 1-2

Authors: Lader, M
Citation: M. Lader, Rating scales in schizophrenia - A review of their usefulness for assessing atypical antipsychotics, CNS DRUGS, 14(1), 2000, pp. 23-32

Authors: Brunello, N den Boer, JA Judd, LL Kasper, S Kelsey, JE Lader, M Lecrubier, Y Lepine, JP Lydiard, RB Mendlewicz, J Montgomery, SA Racagni, G Stein, MB Wittchen, HU
Citation: N. Brunello et al., Social phobia: diagnosis and epidemiology, neurobiology and pharmacology, comorbidity and treatment, J AFFECT D, 60(1), 2000, pp. 61-74

Authors: Rees, K Allen, D Lader, M
Citation: K. Rees et al., The influences of age and caffeine on psychomotor and cognitive function, PSYCHOPHAR, 145(2), 1999, pp. 181-188

Authors: Lader, M
Citation: M. Lader, Handbook of substance abuse neurobehavioral pharmacology, ADDICTION, 94(6), 1999, pp. 928-929

Authors: Lader, M
Citation: M. Lader, Designer drugs directory, ADDICTION, 94(10), 1999, pp. 1588-1588

Authors: Lader, M
Citation: M. Lader, Anxiolytic effect of hydroxyzine: A double-blind trial versus placebo and buspirone, HUM PSYCHOP, 14, 1999, pp. S94-S102

Authors: Kapczinski, F Quevdo, J Curran, HV Fleminger, S Toone, B Cluckie, A Lader, M
Citation: F. Kapczinski et al., Brain uptake of iomazenil in cirrhotic patients: a single photon emission tomography study, J PSYCHOPH, 13(3), 1999, pp. 219-225

Authors: Lader, M
Citation: M. Lader, Some adverse effects of antipsychotics: Prevention and treatment, J CLIN PSY, 60, 1999, pp. 18-21

Authors: Lader, M
Citation: M. Lader, The influence of drugs upon testimony, MED SCI LAW, 39(2), 1999, pp. 99-105

Authors: Lader, M
Citation: M. Lader, Withdrawal reactions after stopping hypnotics in patients with insomnia, CNS DRUGS, 10(6), 1998, pp. 425-440

Authors: Lader, M
Citation: M. Lader, The clinical relevance of treating social phobia, J AFFECT D, 50, 1998, pp. S29-S34
Risultati: 1-18 |